Senior Manager, Medical Content Product Manager– Content Platforms & Delivery (CP&D) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Commercialization (Commercial + Medical) domain & digital capability solutions experience
Understanding of content management and ability to define processes that span the content lifecycle
Excellent collaboration and communication skills, with the ability to build strong partnerships
Proactive, self-accountable, and takes initiative in identifying opportunities and forming projects to achieve those goals
Ability to clearly articulate and translate technical elements in business terms, and vice versa
Demonstrated ability to communicate, influence and partner with senior leaders
Ability to lead the analysis of complex business needs and translate them into deployable technology solutions by developing/owning/managing them

Responsibilities

Own and articulate the product vision, strategy, and multi-release roadmap for Veeva Vault MedComms and adjacent Medical content capabilities
Lead product discovery with Medical/MI stakeholders and field users; translate insights into epics, user stories, and acceptance criteria
Prioritize and groom the backlog to balance regulatory compliance, business value, risk, and technical feasibility; run effective PI/iteration planning in partnership with Delivery
Define product OKRs and KPIs (e.g., content cycle time, global-to-local reuse, adoption, search efficacy, field-medical engagement) and manage to outcomes
Ensure validated delivery (CSV/SDLC): author change controls, oversee test evidence, and lead release governance for triannual Vault updates and interim changes
Coordinate incident, problem, and demand management; drive RCA and preventive actions with vendors (e.g., Veeva) and internal teams
Partner with Solution Architecture on reference designs and integrations (e.g., Veeva CRM, Medical Information portals such as PhactMI/MIO, analytics/visualization, taxonomy services)
Steward content data model and metadata/taxonomy standards (scientific statements, references) to enable global consistency and reuse
Champion change management and enablement (communications, training, release notes), accelerating adoption and continuous improvement
Evaluate responsible AI/ML opportunities (e.g., assisted authoring, auto-tagging, semantic search) under enterprise governance; pilot and scale proven use cases
Manage vendor relationships, SOWs/licensing inputs, and contribute to budgeting/forecasting for product areas
Understand content componentization and development of capabilities that set up foundational content to enable AI and automation

Skills

Veeva Vault

Veeva Vault MedComms

Product Management

Product Roadmap

User Stories

Epics

Backlog Grooming

PI Planning

OKRs

KPIs

Medical Communications

Content Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free